Redefining drug-nutrient interactions

Nutrition in Clinical Practice

Volumn 15, Issue 5, 2000, Pages 249-252

  Chan, Lingtak Neander ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000578672     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/088453360001500508     Document Type: Article

References (23)

1. Bessman S, Doorenbos N: Chelation. [Editorial] Ann Intern Med 47:1036-1041, 1957.
2. Bauer LA: Interference of oral phenytoin absorption by continuous nasogastric feedings. Neurology 32(5):570-572, 1982.
3. Ozuna J, Friel P: Effect of enteral tube feeding on serum phenytoin levels. J Neurosurg Nurs 16(6):289-291, 1984.
4. A.S.P.E.N. Board of Directors. Standard of practice for nutrition support pharmacists. Nutr Clin Pract 14(5):275-281, 1999.
5. Mueller BA, Brierton DG, Abel SR, et al: Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin. Antimicrob Agents Chemother 38(9):2101-2105, 1994.
6. Mimoz O, Binter V, Jacolot A, et al: Pharmacokinetics and absolute bioavailability of ciprofloxacin administered through a nasogastric tube with continuous enteral feeding to critically ill patients. Intensive Care Med 24(10):1047-1051, 1998.
7. Pirsch JD, Armbrust MJ, Knechtle SJ, et al: Obesity as a risk factor following renal transplantation. Transplantation 59:631-647, 1995.
8. Shane E, Rivas M, McMahon DJ, et al: Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab 82(5): 1497-1506, 1997.
9. 1997 Comprehensive Accreditation Manual for Hospitals. Chicago. Joint Commission on Accreditation of Healthcare Organizations, 1997.
10. Garg SK, Kumar N, Bhargava VK, et al: Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy. Clin Pharmacol Ther 64:286-288, 1998.
11. Lewis DP, Van Dyke DC, Willhite LA, et al: Phenytoin-folic acid interaction. Ann Pharmacother 29:726-735, 1995.
12. Chang T, Benet LA, Hebert MF: The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers. Clin Pharmacol Ther 59:297-303, 1996.
13. Ducharme MP, Warbasse LH, Edwards DJ: Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther 57:485-491, 1995.
14. Fuhr U: Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance. Drug Saf 18(4):251-272, 1998.
15. Melia AT, Koss-Twardy SG, Zhi J: The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers. J Clin Pharmacol 36(7):647-653, 1996.
16. Neuvonen PJ, Kivisto KT, Lehto P: Interference of dairy products with the absorption of ciprofloxacin. Clin Pharmacol Ther 50(5 Pt 1):498-502, 1991.
17. Booth SL, Centurelli MA: Vitamin K: A practical guide to the dietary management of patients on warfarin. Nutr Rev 57(9 Pt 1):288-296, 1999.
18. Wald JA, Jusko WJ: Corticosteroid pharmacodynamic modeling: Osteocalcin suppression by prednisolone. Pharm Res 9(8): 1096-1098, 1992.
19. Nielsen HK, Brixen K, Kassem M, et al: Acute effect of 1, 25-dihydroxyvitamin D3, prednisone, and 1, 25-dihydroxyvitamin D3 plus prednisone on serum osteocalcin in normal individuals. J Bone Miner Res 6(5):435-441, 1991.
20. Triggs WJ, Bohan TP, Lin SN, et al: Valproate-induced coma with ketosis and carnitine insufficiency. Arch Neurol 47:1131-1133, 1990.
21. Ohtani Y, Endo F, Matsuda I: Carnitine deficiency with hyperammonemia associated with valproic acid therapy. J Pediatr "101:782-785, 1982.
22. Triggs WJ, Gilmore RL, Millington DS, et al: Valproate-associ-ated carnitine deficiency and malignant cerebral edema in the absence of hepatic failure. Int J Clin Pharmacol Ther 35(9):353-356, 1997.
23. Bennett WM: Drug interactions and consequences of sodium restriction. Am J Clin Nutr 65(2 Suppl):678S-681, 1997